Vevo Therapeutics is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company's Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Vevo is using Mosaic to build the world's largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/09/22	$12,000,000	Seed	AIX Ventures Camford Capital General Catalyst Partners Mubadala Capital Wing Venture Capital	undisclosed